Dr Guillaume Leurent, MD is an expert in Cardiology at Centre Hospitalier Universitaire de Rennes (France). Guillaume Leurent has authored 210 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 4 of them ongoing. SLR score: 847 (community average: 125). How the SLR is computed.

LeadR Profile

Dr Guillaume Leurent, MD Centre Hospitalier Universitaire de Rennes France
847 ScienceLeadR Reputation 847
Network Map

Cardiology

Subspecialties: Public Health - Critical Care - Biostatistics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2006 - 2026

Source: PubMed

Centre Hospitalier Universitaire de Rennes

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Predictors of cardiac rehabilitation completion after acute myocardial infarction in young women: the French WAMIF Registry.
PMID 42729979 — registries, absenteeism, myocardial infarction, cardiac rehabilitation, rehabilitation, st elevation myocardial infarction, risk factors
Eur Heart J Open20260
Outcomes of patients with large anatomies undergoing transcatheter tricuspid valve replacement with the LuX-Valve Plus system.
PMID 42610335 — tricuspid valve, cardiac surgical procedures, anatomy
EuroIntervention20260
Comparison of Local Investigator and Core Laboratory Assessment of Cardiac MRI-derived Left Ventricular Ejection Fraction in the MyocarditIRM Study.
PMID 42560173 — laboratories
Radiol Cardiothorac Imaging20260
Left atrial remodeling and diastolic unloading after transcatheter tricuspid repair.
PMID 42462168 — atrial remodeling, physiology, heart failure
ESC Heart Fail20260
Age-associated outcomes in cardiogenic shock supported with microaxial flow pumps.
PMID 42403523 — mortality, shock, cardiogenic, recycling
Ann Intensive Care20261

Clinical Studies 18

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

N/A 18

By status:

Completed 8
Recruiting 6
Active not recruiting 3
Unknown 1

By type:

Interventional 11
Observational 7

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 0
multicentric5to9 0
multicentricup10 11

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

4 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation APOLLO EU Trial
NCT05496998 — lymphoma, follicular, constriction, pathologic, mitral valve, lymphoma, therapeutics, mitral valve stenosis, gastroesophageal reflux, mitral valve insufficiency, transcatheter mitral valve replacement
N/ARecruiting2023
Evaluation of the Efficacy of Early Implantation of a Percutaneous Left Ventricular Assist Devices in Acute Coronary Syndrome Complicated by Cardiogenic Shock Compared to Conventional Therapy a Prospective Multicenter Randomized Controlled and Open label Clinical Trial
NCT05366452 — shock, cardiogenic, acute coronary syndrome, angiography, therapeutics, punctures, random allocation
N/ARecruiting2022
The TRICURE First in Human Trial
NCT05126030 — heart, tricuspid valve, tricuspid valve insufficiency, heart valves
N/AActive not recruiting2022
HighFLO Study HighLife Trans septal Mitral Valve Replacement (TSMVR) Feasibility Study of the Open Cell CLARITY Valve
NCT04888247 — cells, feasibility studies, mitral valve, mitral valve insufficiency
N/ARecruiting2021

LeadR Networks

Main global connection map